Integra LifeSciences Reports Fourth Quarter and Full-Year 2017 Financial Results

Integra LifeSciences (NASDAQ:IART) today reported financial results for the fourth quarter and full-year ended December 31, 2017.

As quoted in the press release:

The Company completed the acquisition of Codman Neurosurgery, the largest in its history, on October 2, 2017;
Reported revenue for the full-year 2017 was $1,188.2 million, an increase of 19.8%, or $196.2 million over the prior year; acquisitions contributed $162.1 million to the full year, while organic sales were higher by 4.6% over the prior year.
Fourth quarter revenue was $368.6 million, an increase of 44.2%, or $112.9 million over the prior year quarter; acquisitions contributed $103.3 million to the fourth quarter, while organic sales were higher by 5.8% over the prior year quarter;

Click here to read the full press release.